News

You can still find attractive stocks despite all of the turbulence. Many stocks have been losers in 2025 amid the market chaos, but not Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). Shares of Warren ...
Vertex AI souped up, Ironwood TPU, agent SDK and Cloud WAN for companies: These are just some of the highlights from the ...
Zacks Research bumped up Vertex Pharmaceuticals’ Q1 2027 earnings forecast by a thrilling one cent, now expecting $4.24 per ...
Learn more about whether Bitdeer Technologies Group or Vertex, Inc. is a better investment based on AAII's A+ Investor grades ...
Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...
Vertex Pharmaceuticals got a healthy boost on Tuesday, with shares climbing nearly 3% thanks to a double dose of analyst ...
Vertex Pharmaceuticals ( VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech 's shares closed the day nearly 3% ...
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Learn more about whether SoundHound AI, Inc. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which ...
According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.62%, ...
Google Cloud's updated its Vertex AI platform to support AI agents with including the Agent Development Kit, the Agent2Agent ...